Insider Transactions in Q2 2025 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,916
+14.04%
|
-
|
|
May 21
2025
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+2.44%
|
-
|
|
May 21
2025
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+19.55%
|
-
|
|
May 21
2025
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+17.09%
|
-
|
|
May 21
2025
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+15.09%
|
-
|
|
May 21
2025
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+19.05%
|
-
|
|
May 21
2025
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+17.99%
|
-
|
|
May 21
2025
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+19.89%
|
-
|
|
May 15
2025
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,708
-4.98%
|
$1,708
$1.95 P/Share
|
|
May 15
2025
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,771
+12.2%
|
-
|
|
May 15
2025
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,566
-7.82%
|
$2,566
$1.95 P/Share
|
|
May 15
2025
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,771
+12.69%
|
-
|
|
May 15
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,717
-11.45%
|
$7,717
$1.95 P/Share
|
|
May 15
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,744
+20.84%
|
-
|
|
May 15
2025
|
Michael John Sumner Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-4.36%
|
$680
$1.95 P/Share
|
|
May 15
2025
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,385
+13.25%
|
-
|
|
May 10
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,392
-4.6%
|
$2,392
$1.8 P/Share
|
|
May 10
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+9.56%
|
-
|